Cargando…
Clinical implications of AGBL2 expression and its inhibitor latexin in breast cancer
BACKGROUND: We investigated the expression status of AGBL2 and its inhibitor latexin in breast cancer stem cells and its clinical implications in order to lay a foundation for managing breast cancer. METHODS: CD44+/CD24- tumor cells (CSC) from clinical specimens were sorted using flow cytometry. AGB...
Autores principales: | Zhang, Hao, Ren, Yuan, Pang, Deyan, Liu, Caigang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4069086/ https://www.ncbi.nlm.nih.gov/pubmed/24884516 http://dx.doi.org/10.1186/1477-7819-12-142 |
Ejemplares similares
-
Expression of RARRES1 and AGBL2 and progression of conventional renal cell carcinoma
por: Peterfi, Lehel, et al.
Publicado: (2020) -
High expression of AGBL2 is a novel prognostic factor of adverse outcome in patients with ovarian carcinoma
por: He, Wei-Peng, et al.
Publicado: (2019) -
Self-assembly of human latexin into amyloid-like oligomers
por: Pallarés, Irantzu, et al.
Publicado: (2007) -
Is concomitant splenectomy beneficial for the long-term survival of patients with gastric cancer undergoing curative gastrectomy? A single-institution study
por: Zhang, Hao, et al.
Publicado: (2014) -
Latexin expression is downregulated in human gastric carcinomas and exhibits tumor suppressor potential
por: Li, Yong, et al.
Publicado: (2011)